George Washington University
Washington D.C., District of Columbia, 20037, United States
NCT Number: NCT00636844
To identify patients that are at risk of heart damage after receiving chemotherapy (adriamycin).
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Washington D.C., District of Columbia, 20037, United States
To identify patients at risk of development of heart damage after receiving chemotherapy by obtaining the genetic profile of those who show: elevation of troponin, left ventricular systolic and diastolic dysfunction, and pro-oxidant stress markers.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: one year
Time frame: one year
Time frame: one year
George Washington University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04598646
Behavior, Cancer
Toronto, Ontario, Canada
View Trial DetailsNCT04036032
Cancer, Cardiotoxicity
Hartford, Connecticut, United States
View Trial DetailsNCT05403736
Breast Diseases, Breast Neoplasms
Los Angeles, California, United States
View Trial DetailsNCT04486573
Cancer, Cardiotoxicity
Aurora, Colorado, United States
View Trial Details